Prescription and over-the-counter medications
Nephron Pharmaceuticals Corporation
GMP Deviations: potential glass contamination
Nephron Pharmaceuticals Corporation
GMP Deviations: potential glass contamination
Nephron Pharmaceuticals Corporation
Lack of Assurance of Sterility; bags have potential to leak
Nephron Pharmaceuticals Corporation
GMP Deviations: potential glass contamination
Avella of Deer Valley, Inc. Store 38
Lack of sterility assurance.
Presence of Foreign Substance; Fiber particles.
Atlas Pharmaceuticals
Labeling: Not Elsewhere Classified; product is labeled as "Non-Corn Source" however the product is from a corn source.
Ingenus Pharmaceuticals
Crystallization: Presence of particulate matter identified as API crystallization
Superpotent Drug: Amphetamine Mixed Salts 20mg have been found to be out of specification for weight and thickness.
Superpotent
Spectrum Laboratory Products
CGMP Deviations: Received notice from supplier that there is potential glass contamination.
Jubilant Cadista Pharmaceuticals
CGMP Deviation: Presence of dark brown discoloration on edges of tablets.
Lack of Assurance of Sterility: Bag has the potential to leak.
CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.
Microbial Contamination of Non-Sterile Product.
CGMP Deviations: Detection of a trace amount of an unexpected impurity, N-nitrosodimethylamine (NDMA).
CGMP Deviations: Detection of a trace amount of an unexpected impurity, N-nitrosodimethylamine (NDMA).
Labeling: Not Elsewhere Classified: RFID formatting error which reads product in Ultraject syringe as expired and will not allow injection of product by the Optivantage injector.
Presence of Foreign Tablets/Capsules: Estradiol 1 mg was found in a 100 count bottle of Estradiol 0.5 mg Tablets.
GMP Deviation: lot not intended for commercial distribution.